Verquvo and Ill-defined disorder - a phase IV clinical study of FDA data

Summary:

Ill-defined disorder is reported as a side effect among people who take Verquvo (vericiguat), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Lipitor, and have Cardiac failure.

The phase IV clinical study analyzes which people have Ill-defined disorder when taking Verquvo. It is created by eHealthMe based on reports of 577 people who have side effects when taking Verquvo from the FDA, and is updated regularly.

What is Verquvo?

Verquvo has active ingredients of vericiguat. eHealthMe is studying from 577 Verquvo users. Check the latest studies of Verquvo.

What is Ill-defined disorder?

Ill-defined disorder is found to be associated with 1,464 drugs and 1,258 conditions by eHealthMe. Check the latest studies of Ill-defined disorder.

On Jul, 20, 2026

577 people reported to have side effects when taking Verquvo.
Among them, 16 people (2.77%) have Ill-defined disorder.

Could Verquvo cause Ill-defined disorder?

Among these 16 people:

How long have people been on Verquvo when they have Ill-defined disorder? *

What is the gender of people who have Ill-defined disorder when taking Verquvo? *

female: 25 %
male: 75 %

What is the age of people who have Ill-defined disorder when taking Verquvo? *

What are other drugs people take besides Verquvo? *

What are other side effects people have besides Ill-defined disorder? *

Death: 6 people, 37.50%
Hypotension (abnormally low blood pressure): 5 people, 31.25%
Oedema Peripheral (superficial swelling): 2 people, 12.50%
Weakness: 2 people, 12.50%
Atelectasis (partial or complete collapse of the lung): 1 person, 6.25%
Dizziness: 1 person, 6.25%
Acute Kidney Failure: 1 person, 6.25%
Hepatic Steatosis (fatty liver disease): 1 person, 6.25%
Heart Attack: 1 person, 6.25%
Haemoglobin Decreased: 1 person, 6.25%

What are the existing conditions these people have? *

Cardiac Failure: 3 people, 18.75%
Pain: 2 people, 12.50%
Cardiac Failure Congestive: 2 people, 12.50%
Pulmonary Arteriovenous Fistula: 1 person, 6.25%
Ischaemic Cardiomyopathy (weakness in the muscle of the heart due to inadequate oxygen delivery to the myocardium with coronary artery disease): 1 person, 6.25%
Chronic Left Ventricular Failure (long lasting functional impairment of left ventricle of heart): 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Verquvo and have Ill-defined disorder?

- Check whether Ill-defined disorder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Verquvo:

Verquvo (577 reports)

Browse all side effects of Verquvo:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Ill-defined disorder:

Ill-defined disorder (1,464 drugs)

Browse all the conditions that are associated with Ill-defined disorder:

Ill-defined disorder (1,258 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on vericiguat (the active ingredients of Verquvo) and Verquvo (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.